{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:49:53Z","timestamp":1756075793557},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.177","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T15:45:27Z","timestamp":1466955927000},"page":"647-652","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era"],"prefix":"10.1016","volume":"220","author":[{"given":"Eun Joo","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyn-Hyang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Kyung","family":"Je","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.177_bb0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2459\/JCM.0000000000000262","article-title":"Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?","volume":"16","author":"Prisco","year":"2015","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0020","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1161\/STR.0b013e318266722a","article-title":"Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Furie","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2261-13-31","article-title":"An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol","volume":"13","author":"Apenteng","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0030","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1160\/TH09-05-0327","article-title":"New oral anticoagulant drugs in cardiovascular disease","volume":"104","author":"Ahrens","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0040","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.12703\/P6-93","article-title":"Expanding use of new oral anticoagulants","volume":"6","author":"Weitz","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinte.167.3.246","article-title":"Newly detected atrial fibrillation and compliance with antithrombotic guidelines","volume":"167","author":"Glazer","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0055","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1185\/03007995.2012.708653","article-title":"Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records","volume":"28","author":"Rosenman","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1536\/jhj.42.55","article-title":"Underutilization of anticoagulation therapy in chronic atrial fibrillation","volume":"42","author":"Guo","year":"2001","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1747-4949.2011.00667.x","article-title":"Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation","volume":"7","author":"Yu","year":"2012","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0070","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1253\/circj.CJ-10-1119","article-title":"Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry","volume":"75","author":"Atarashi","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0075","first-page":"S284","article-title":"A pharmacoeconomic perspective on stroke prevention in atrial fibrillation","volume":"16","author":"Fendrick","year":"2010","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061979","article-title":"Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom","volume":"8","author":"Mohammed","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1070-3241(00)26002-1","article-title":"Improving management of atrial fibrillation and anticoagulation in a community hospital","volume":"26","author":"Gaughan","year":"2000","journal-title":"Jt Comm. J. Qual. Improv."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0090","first-page":"S297","article-title":"Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice","volume":"10","author":"Wittkowsky","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.18553\/jmcp.2013.19.4.302","article-title":"The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective","volume":"19","author":"Casciano","year":"2013","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1474-4422(07)70264-8","article-title":"Atrial fibrillation and stroke prevention","volume":"6","author":"Lip","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0110","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjmed.2009.11.015","article-title":"Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?","volume":"123","author":"Zimetbaum","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jjcc.2015.06.013","article-title":"Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea","author":"Lee","year":"2015","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0135","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0140","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0150","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0155","first-page":"258","article-title":"CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2013","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0165","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm A","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2013.15.1.2","article-title":"Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke","volume":"15","author":"Hong","year":"2013","journal-title":"J. Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4070\/kcj.2015.45.1.9","article-title":"The Korean Heart Rhythm Society's 2014 statement on antithrombotic therapy for patients with nonvalvular atrial fibrillation: Korean Heart Rhythm Society","volume":"45","author":"Jung","year":"2015","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0185","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0190","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5853\/jos.2015.17.2.210","article-title":"Antithrombotic management of patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack: executive summary of the Korean clinical practice guidelines for stroke","volume":"17","author":"Jung","year":"2015","journal-title":"J. Stroke"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0200","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0205","article-title":"Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the ncdr pinnacle registry","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11239-014-1136-8","article-title":"Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use","volume":"40","author":"Wilke","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2016.06.177_bb0215","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2013.08.005","article-title":"Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy","volume":"166","author":"Fosbol","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0220","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.177_bb0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ahj.2014.04.007","article-title":"Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3\u20134, 2012","volume":"168","author":"Hess","year":"2014","journal-title":"Am. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T01:53:34Z","timestamp":1656726814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316311986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":45,"alternative-id":["S0167527316311986"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.177","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}